Tonghua Dongbao Pharmaceutical Co Ltd (600867) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥62.99 Million ≈ $9.22 Million USD) by net assets (CN¥7.14 Billion ≈ $1.04 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Tonghua Dongbao Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Tonghua Dongbao Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Tonghua Dongbao Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600867 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Tonghua Dongbao Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tonghua Dongbao Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangzhong Pharmaceutical Co Ltd
SHG:600750
|
-0.001x |
|
Prestige Brand Holdings Inc
NYSE:PBH
|
0.027x |
|
National Energy Services Reunited Corp Ordinary Shares
NASDAQ:NESR
|
0.143x |
|
CESC Limited
NSE:CESC
|
0.120x |
|
Gudang Garam Tbk
JK:GGRM
|
0.037x |
|
Jiangxi Special Electric Motor Co Ltd
SHE:002176
|
-0.004x |
|
AviChina Industry & Technology Company Limited
F:AVT
|
-0.077x |
|
Bank of Xi'An Co Ltd
SHG:600928
|
0.403x |
Annual Cash Flow Conversion Efficiency for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Tonghua Dongbao Pharmaceutical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.11 Billion ≈ $1.04 Billion |
CN¥689.23 Million ≈ $100.86 Million |
0.097x | +35.00% |
| 2024-12-31 | CN¥6.40 Billion ≈ $936.58 Million |
CN¥459.74 Million ≈ $67.27 Million |
0.072x | -39.83% |
| 2023-12-31 | CN¥7.22 Billion ≈ $1.06 Billion |
CN¥861.52 Million ≈ $126.07 Million |
0.119x | -9.40% |
| 2022-12-31 | CN¥6.55 Billion ≈ $958.41 Million |
CN¥863.09 Million ≈ $126.30 Million |
0.132x | -27.75% |
| 2021-12-31 | CN¥6.22 Billion ≈ $910.21 Million |
CN¥1.13 Billion ≈ $166.02 Million |
0.182x | -14.95% |
| 2020-12-31 | CN¥5.56 Billion ≈ $813.52 Million |
CN¥1.19 Billion ≈ $174.47 Million |
0.214x | -6.77% |
| 2019-12-31 | CN¥5.01 Billion ≈ $732.95 Million |
CN¥1.15 Billion ≈ $168.60 Million |
0.230x | +24.18% |
| 2018-12-31 | CN¥4.73 Billion ≈ $692.77 Million |
CN¥876.94 Million ≈ $128.32 Million |
0.185x | -12.56% |
| 2017-12-31 | CN¥4.54 Billion ≈ $663.97 Million |
CN¥961.19 Million ≈ $140.65 Million |
0.212x | +15.15% |
| 2016-12-31 | CN¥3.95 Billion ≈ $577.31 Million |
CN¥725.76 Million ≈ $106.20 Million |
0.184x | +54.81% |
| 2015-12-31 | CN¥2.48 Billion ≈ $362.76 Million |
CN¥294.58 Million ≈ $43.11 Million |
0.119x | +24.69% |
| 2014-12-31 | CN¥2.16 Billion ≈ $316.15 Million |
CN¥205.89 Million ≈ $30.13 Million |
0.095x | -13.08% |
| 2013-12-31 | CN¥2.02 Billion ≈ $295.04 Million |
CN¥221.06 Million ≈ $32.35 Million |
0.110x | +12.35% |
| 2012-12-31 | CN¥1.99 Billion ≈ $291.37 Million |
CN¥194.32 Million ≈ $28.44 Million |
0.098x | +468.21% |
| 2011-12-31 | CN¥2.08 Billion ≈ $304.07 Million |
CN¥-55.07 Million ≈ $-8.06 Million |
-0.027x | -128.63% |
| 2010-12-31 | CN¥1.73 Billion ≈ $253.53 Million |
CN¥160.40 Million ≈ $23.47 Million |
0.093x | -9.39% |
| 2009-12-31 | CN¥1.63 Billion ≈ $238.04 Million |
CN¥166.20 Million ≈ $24.32 Million |
0.102x | +58.67% |
| 2008-12-31 | CN¥1.43 Billion ≈ $209.78 Million |
CN¥92.31 Million ≈ $13.51 Million |
0.064x | -18.33% |
| 2007-12-31 | CN¥1.53 Billion ≈ $224.47 Million |
CN¥120.94 Million ≈ $17.70 Million |
0.079x | -36.33% |
| 2006-12-31 | CN¥1.28 Billion ≈ $186.72 Million |
CN¥158.00 Million ≈ $23.12 Million |
0.124x | +80.01% |
| 2005-12-31 | CN¥1.34 Billion ≈ $196.19 Million |
CN¥92.23 Million ≈ $13.50 Million |
0.069x | +592.91% |
| 2004-12-31 | CN¥1.33 Billion ≈ $194.05 Million |
CN¥13.17 Million ≈ $1.93 Million |
0.010x | -69.43% |
| 2003-12-31 | CN¥1.40 Billion ≈ $205.04 Million |
CN¥45.51 Million ≈ $6.66 Million |
0.032x | +38.36% |
| 2002-12-31 | CN¥1.36 Billion ≈ $199.45 Million |
CN¥31.99 Million ≈ $4.68 Million |
0.023x | -72.51% |
| 2001-12-31 | CN¥1.38 Billion ≈ $201.72 Million |
CN¥117.73 Million ≈ $17.23 Million |
0.085x | +317.87% |
| 2000-12-31 | CN¥1.43 Billion ≈ $208.52 Million |
CN¥29.12 Million ≈ $4.26 Million |
0.020x | +130.19% |
| 1999-12-31 | CN¥1.40 Billion ≈ $205.54 Million |
CN¥-95.09 Million ≈ $-13.91 Million |
-0.068x | +71.02% |
| 1998-12-31 | CN¥928.90 Million ≈ $135.93 Million |
CN¥-216.98 Million ≈ $-31.75 Million |
-0.234x | -- |
About Tonghua Dongbao Pharmaceutical Co Ltd
Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug tr… Read more